Exploring new pathways in the treatment of hepatocellular cancer.
作者信息
Masior Łukasz, Grąt Michał
机构信息
Department of General, Vascular and Oncological Surgery, Medical University of Warsaw, Warsaw, Poland.
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
出版信息
Ann Transl Med. 2020 Aug;8(16):980. doi: 10.21037/atm-20-3629.
Abstract
摘要
相似文献
1
Exploring new pathways in the treatment of hepatocellular cancer.
Ann Transl Med. 2020 Aug;8(16):980. doi: 10.21037/atm-20-3629.
2
Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma.
Onco Targets Ther. 2020 Oct 6;13:9901-9916. doi: 10.2147/OTT.S267812. eCollection 2020.
3
Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma.
Channels (Austin). 2021 Dec;15(1):541-554. doi: 10.1080/19336950.2021.1968592.
4
miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma.
J Biomed Inform. 2018 May;81:31-40. doi: 10.1016/j.jbi.2018.03.013. Epub 2018 Mar 22.
5
Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinoma.
Tumour Biol. 2018 May;40(5):1010428318773675. doi: 10.1177/1010428318773675.
6
Extracellular matrix transcriptome dynamics in hepatocellular carcinoma.
Matrix Biol. 2013 Oct-Nov;32(7-8):393-8. doi: 10.1016/j.matbio.2013.05.003. Epub 2013 May 29.
7
Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology.
Crit Rev Oncol Hematol. 2016 Sep;105:65-72. doi: 10.1016/j.critrevonc.2016.06.007. Epub 2016 Jun 16.
8
The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
World J Surg Oncol. 2018 Feb 21;16(1):36. doi: 10.1186/s12957-018-1342-5.
9
The effect of alendronate on proteome of hepatocellular carcinoma cell lines.
Int J Proteomics. 2014;2014:532953. doi: 10.1155/2014/532953. Epub 2014 Feb 6.
10
[Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jul 10;40(7):805-809. doi: 10.3760/cma.j.issn.0254-6450.2019.07.014.
本文引用的文献
1
Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.
Liver Int. 2020 Aug;40(8):1997-2007. doi: 10.1111/liv.14463. Epub 2020 May 23.
2
The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention-to-Treat Analysis.
Liver Transpl. 2020 Jul;26(7):878-887. doi: 10.1002/lt.25768. Epub 2020 Jun 25.
3
Recent Advances in Immunotherapy for Hepatocellular Carcinoma.
Cancers (Basel). 2020 Mar 25;12(4):775. doi: 10.3390/cancers12040775.
4
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Transplantation. 2020 Jun;104(6):1136-1142. doi: 10.1097/TP.0000000000003174.
5
Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments.
Pharmacol Ther. 2020 Jul;211:107527. doi: 10.1016/j.pharmthera.2020.107527. Epub 2020 Mar 12.
6
The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.
Medicine (Baltimore). 2020 Feb;99(7):e19075. doi: 10.1097/MD.0000000000019075.
7
Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy.
Ann Transl Med. 2019 Dec;7(23):739. doi: 10.21037/atm.2019.11.131.
8
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study.
Transpl Int. 2020 May;33(5):567-575. doi: 10.1111/tri.13586. Epub 2020 Feb 20.
9
A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
HPB (Oxford). 2020 Jun;22(6):795-808. doi: 10.1016/j.hpb.2019.12.013. Epub 2020 Jan 21.
10
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis.
Life Sci. 2020 Feb 1;242:117181. doi: 10.1016/j.lfs.2019.117181. Epub 2019 Dec 18.
Zotero 插件